NCT07104344 Study of CM355 in Patients With Systemic Lupus Erythematosus Status NOT_YET_RECRUITING Phase NA
NCT07102238 Lupus Arthritis: Muscoloskeletal Ultrasound as Clinical Outcome of Peripheral Blood and Synovial Deep Phenotyping Status ACTIVE_NOT_RECRUITING Phase NA
NCT07102030 Subgrouping SLE - a New Approach to Understand the Pathogenesis and Improve Treatment Status RECRUITING Phase N/A
NCT07096557 The Effect of Co-enzyme Q10 on the Clinical Outcome of Pediatric Patients With Systemic Lupus Erythematosus Status COMPLETED Phase PHASE2
NCT07077486 Effects of Telitacicept vs Cyclophosphamide on Lupus Related Interstitial Lung Disease Status RECRUITING Phase PHASE4
NCT07077304 EACVI Study on Multimodality Cardiovascular Imaging of Inflammatory Cardiovascular Diseases Status RECRUITING Phase N/A
NCT07069972 A Prospective Comparative Study Involving Multiple Units to Evaluate the Efficacy and Safety of Telitacicept and Belimumab in the Treatment of Systemic Lupus Erythematosus. Status NOT_YET_RECRUITING Phase N/A
NCT07053137 A Comparative Study of the Efficacy and Safety of Telitacicept and Belimumab in the Treatment of Systemic Lupus Erythematosus Involving Multiple Units, Based on Previous Data. Status ACTIVE_NOT_RECRUITING Phase N/A
NCT07048470 Efficacy of Synbiotic Supplementation on IL-10, TGF-B and Disease Activity in Systemic Lupus Erythematosus Patients Status COMPLETED Phase NA
NCT07038447 A Study of KITE-363 in Participants With Refractory Autoimmune Diseases Status ENROLLING_BY_INVITATION Phase PHASE1
NCT07011043 A Phase 1b Study of Budoprutug in Systemic Lupus Erythematosus (SLE) Status RECRUITING Phase PHASE1
NCT07005479 Long-Term Outcomes in SLE at Peking University People's Hospital Status RECRUITING Phase N/A
NCT07001839 A Phase Ib Study of QLS4131 in Subjects With Systemic Lupus Erythematosus Status NOT_YET_RECRUITING Phase PHASE1
NCT07000916 Medical Follow-up of New Cases of Polyarthritis in Children and Young Adults Status RECRUITING Phase N/A
NCT06984341 A Study to Evaluate the Safety, Tolerability, Cellular Kinetics, Pharmacodynamics, and Efficacy of P-CD19CD20-ALLO1 in Participants With Severe, Treatment-refractory Systemic Lupus Erythematosus (SLE) Status WITHDRAWN Phase PHASE1
NCT06978738 UCAR T-cell Therapy Targeting CD19/ BCMA in Patients With Relapse/ Refractory Autoimmune Diseases Status NOT_YET_RECRUITING Phase PHASE1